Unither's R&D, Marketing and Innovation divisions work closely together and form a single set of core skills at your service. Unither can provide you with access to a team of specialists: Unither Développement.
By adopting your corporate values and brand ethos and by taking into account your product's commercial and technical environment, the Unither Développement team can find the right solution for meeting your needs and breathe new life into your products.
Unither Développement will never publicize itself to your partners or customers. Unither's results speak for themselves and attest to the company's high performance levels. You will work hand-in-hand with our engineers and innovation specialists.We always take account of the target cost price and economic realities.
Unither Développement is based in Bordeaux and is renowned for its skill and expertise - particularly in the field of pharmaceutical innovation. The division is active in the following areas:
Pharmaceutical development
- preformulation studies (with new active compounds)
- formulation
- industrial scale-up/ validation of process
A team of formulation experts (supervised by a pharmacist and an engineer) develop around twenty formulae a year, including the following pharmaceutical forms:
Tablets, coated tablets, effervescent tablets, capsules, sachets, syrups, solutions, creams, ointments and gels. Modified-release dry forms can also be developed.
Analytical development
- development and validation of analytical methods
- temperature- and humidity-mapped storage chambers, under ICH conditions
- stability studies
- dissolution studies
- quality control
Production and packaging
- pilot batches
- clinical batches
- batches for stability studies
- orphan drugs
Stability studies
- marketed drugs
- investigational products
Quality control (audit and batch release)
Drafting section 3 of Common Technical Documents (CTDs) and Investigational Medicinal Product Dossiers (IMPDs).
As part of an industrial group, Unither Développement provides its customers with 2 key assets:
- integration of industrial constraints during the product development phase and thus optimization of manufacturing costs.
- total product development, from formulation to manufacture.
